Literature DB >> 21047580

Chronic thromboembolic pulmonary hypertension.

William R Auger1, Nick H Kim, Terence K Trow.   

Abstract

Chronic thromboembolic pulmonary hypertension is one of the few forms of pulmonary hypertension that is surgically curable. It is likely underdiagnosed and must be considered in every patient presenting with pulmonary hypertension to avoid missing the opportunity to cure these patients. This article discusses the epidemiology, risk factors, natural history, diagnosis, and preoperative evaluation of patients with this disorder. Also covered are putative mechanisms for the conversion of acute emboli into fibrosed thrombembolic residua. Mechanical obstruction of the central pulmonary vasculature is rarely the sole cause of the pulmonary hypertension, and a discussion of the small vessel arteriopathy present in these patients is offered. Technical aspects of pulmonary endartectomy and the data supporting its role are discussed, as are the limited data on pulmonary arterial hypertension specific medical therapies for patients deemed noncandidates for the operation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21047580     DOI: 10.1016/j.ccm.2010.07.006

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  8 in total

1.  Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Chakkarin Burudpakdee; Anshul Shah; Vijay N Joish; Christine Divers; Avin Yaldo
Journal:  Am Health Drug Benefits       Date:  2014-12

2.  Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension: How can patients be better selected?

Authors:  Juan C Grignola; Enric Domingo
Journal:  World J Cardiol       Date:  2013-03-26

3.  Impact of CT perfusion imaging on the assessment of peripheral chronic pulmonary thromboembolism: clinical experience in 62 patients.

Authors:  Julien Le Faivre; Alain Duhamel; Suonita Khung; Jean-Baptiste Faivre; Nicolas Lamblin; Jacques Remy; Martine Remy-Jardin
Journal:  Eur Radiol       Date:  2016-03-14       Impact factor: 5.315

Review 4.  Chronic Thromboembolic Pulmonary Hypertension: Pearls and Pitfalls of Diagnosis.

Authors:  Humna Abid Memon; C Huie Lin; Ashrith Guha
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 5.  Advances in the management of chronic thromboembolic pulmonary hypertension.

Authors:  Demosthenes G Papamatheakis; Nick H Kim
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

6.  ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.

Authors:  Carlo D'Agostino; Pietro Zonzin; Iolanda Enea; Michele Massimo Gulizia; Walter Ageno; Piergiuseppe Agostoni; Michele Azzarito; Cecilia Becattini; Amedeo Bongarzoni; Francesca Bux; Franco Casazza; Nicoletta Corrieri; Michele D'Alto; Nicola D'Amato; Andrea Maria D'Armini; Maria Grazia De Natale; Giovanni Di Minno; Giuseppe Favretto; Lucia Filippi; Valentina Grazioli; Gualtiero Palareti; Raffaele Pesavento; Loris Roncon; Laura Scelsi; Antonella Tufano
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

7.  A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty.

Authors:  Takumi Inami; Masaharu Kataoka; Motomi Ando; Keiichi Fukuda; Hideaki Yoshino; Toru Satoh
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

8.  Lung perfusion: MRI vs. SPECT for screening in suspected chronic thromboembolic pulmonary hypertension.

Authors:  Christopher S Johns; Andrew J Swift; Smitha Rajaram; Paul J C Hughes; David J Capener; David G Kiely; James M Wild
Journal:  J Magn Reson Imaging       Date:  2017-04-04       Impact factor: 4.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.